Catalyst Capital Advisors’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-380
Closed -$19K 534
2018
Q1
$19K Hold
380
﹤0.01% 287
2017
Q4
$14K Hold
380
﹤0.01% 291
2017
Q3
$12K Hold
380
﹤0.01% 294
2017
Q2
$7K Buy
+380
New +$7K ﹤0.01% 342